Is Medifyhealth a funded company?

Medifyhealth is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Medifyhealth rank among its competitors?

Medifyhealth ranks 131st amongst 146 active competitors, of which 15 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Ceresti, which secured $10M in May, 2026.

Who are the top competitors of Medifyhealth?

Medifyhealth's top competitors include Ceresti, Aqtual and Evergreen Nephrology. Among them, Ceresti secured the most recent funding round in May, 2026.

Medifyhealth - 2026 Company Profile & Competitors

Medifyhealth is an unfunded company. It operates as a Provider of chronic care management and remote patient monitoring services. Medifyhealth has not raised any funding yet. The company has 146 active competitors, including 15 funded and 15 that have exited. Its top competitors include companies like Ceresti, Aqtual and Evergreen Nephrology.

Company Details

Provider of chronic care management and remote patient monitoring services. The company offers services as an extension of a practice for patient care. They provide health coaches who build personalized suggestions based on lifestyle and needs. The team includes physicians, pharmacists, nurses, and other specialists. They integrate with existing EMR workflows and handle onboarding and registration paperwork.

Key Metrics

Stage

Unfunded

Ranked

131^st among 146 active competitors

Similar Companies

Ceresti & 154 more

View Medifyhealth's full profile

Medifyhealth has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Medifyhealth include Ceresti, Aqtual and Evergreen Nephrology. Here is the list of Top 10 competitors of Medifyhealth, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceresti 2013, Carlsbad (United States), Series B	Provider of chronic care management and monitoring solutions	$36.1M	Prairie Ventures, UCSF Rosenman Institute ... & 4 others	49/100
2nd	Aqtual 2017, San Francisco (United States), Series B	Provider of clinical product launching, chronic disease solution, and diagnostic platform services	$47M	Genoa Ventures, Manta Ray Ventures & 3 others	47/100
3rd	Evergreen Nephrology 2021, Nashville (United States), Series D	Provider of chronic care management services for kidney diseases	$130M	Oak HC/FT, Rubicon Founders & 3 others	43/100
4th	AdaptX 2016, Seattle (United States), Series A	Provider of clinical management solutions	$24.1M	Cercano Management, Arnold Venture Group & 8 others	42/100
5th	Tria Health 2009, Overland Park (United States), Unfunded	Provider of chronic care management services	-	-	38/100
6th	HealthNEXT 2008, Philadelphia (United States), Acquired	Provider of patient management solutions	$200K	Archetype	36/100
7th	Future Cardia 2021, Houston (United States), Series A	Provider of chronic care management services	$5M	La Jolla Holding, Empire Group International	40/100
8th	Pathalys 2021, Raleigh (United States), Series B	Provider of CKD biotherapeutics development services	$105M	Abingworth, TCG Crossover & 9 others	34/100
9th	Brown & Toland 1992, Oakland (United States), Acquired	Provider of healthcare technology and chronic care management services	-	-	34/100
10th	NYAM 1847, United States, Funding Raised	Provider of chronic care services	-	Imls, HHS & 3 others	34/100
131st	Medifyhealth Unfunded	Provider of chronic care management and remote patient monitoring services	-	-	16/100